| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-06 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.0003 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |